Evolving end points for clinical trials in advanced colorectal cancer

Sharlene Gill, Daniel J. Sargent

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

The treatment of advanced colorectal cancer has evolved significantly over recent years. The increasing and justified demand for timely and robust evaluation of emerging therapies has led to the careful evaluation of alternative end points for clinical trials beyond overall survival. This review offers insights into the advantages, limitations, and promise of existing and emerging efficacy end points of interest for advanced colorectal cancer.

Original languageEnglish (US)
Pages (from-to)135-139
Number of pages5
JournalCurrent Colorectal Cancer Reports
Volume5
Issue number3
DOIs
StatePublished - Jul 1 2009

ASJC Scopus subject areas

  • Hepatology
  • Oncology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Evolving end points for clinical trials in advanced colorectal cancer'. Together they form a unique fingerprint.

Cite this